NCT04133909 · Interventional trial
Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level
Overall registry status Completed
Phase 3
Conditions Pulmonary Disease, Chronic Obstructive
Delaware Valley sites
- GSK Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory